<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
<front>
<journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="publisher-id">09-PLCB-RA-0005R3</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1000684</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Cell Biology/Cell Growth and Division</subject><subject>Computational Biology/Synthetic Biology</subject><subject>Computer Science</subject><subject>Molecular Biology/Bioinformatics</subject></subj-group></article-categories><title-group><article-title>Molecular Predictors of 3D Morphogenesis by Breast Cancer Cell Lines in 3D Culture</article-title><alt-title alt-title-type="running-head">Molecular Predictors of 3D Morphogenesis</alt-title></title-group><contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Han</surname><given-names>Ju</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chang</surname><given-names>Hang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Giricz</surname><given-names>Orsi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>Genee Y.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="fn" rid="fn1"><sup>¤</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Baehner</surname><given-names>Frederick L.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gray</surname><given-names>Joe W.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bissell</surname><given-names>Mina J.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kenny</surname><given-names>Paraic A.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Parvin</surname><given-names>Bahram</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group><aff id="aff1"><label>1</label><addr-line>Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, New York, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>Department of Pathology, University of California, San Francisco, San Francisco, California, United States of America</addr-line>       </aff><contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Ohler</surname><given-names>Uwe</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group><aff id="edit1">Duke University, United States of America</aff><author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">B_Parvin@lbl.gov</email></corresp>
<fn fn-type="current-aff" id="fn1"><label>¤</label><p>Current address: Genentech, South San Francisco, California, United States of America</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: BP. Performed the experiments: OG MJB. Analyzed the data: JH HC BP. Contributed reagents/materials/analysis tools: FLB PAK BP. Wrote the paper: JH GYL JWG PAK BP.</p></fn>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn></author-notes><pub-date pub-type="collection"><month>2</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>26</day><month>2</month><year>2010</year></pub-date><volume>6</volume><issue>2</issue><elocation-id>e1000684</elocation-id><history>
<date date-type="received"><day>27</day><month>1</month><year>2009</year></date>
<date date-type="accepted"><day>25</day><month>1</month><year>2010</year></date>
</history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2010</copyright-year><copyright-holder>Han et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
<p>Correlative analysis of molecular markers with phenotypic signatures is the simplest model for hypothesis generation. In this paper, a panel of 24 breast cell lines was grown in 3D culture, their morphology was imaged through phase contrast microscopy, and computational methods were developed to segment and represent each colony at multiple dimensions. Subsequently, subpopulations from these morphological responses were identified through consensus clustering to reveal three clusters of round, grape-like, and stellate phenotypes. In some cases, cell lines with particular pathobiological phenotypes clustered together (e.g., ERBB2 amplified cell lines sharing the same morphometric properties as the grape-like phenotype). Next, associations with molecular features were realized through (i) differential analysis within each morphological cluster, and (ii) regression analysis across the entire panel of cell lines. In both cases, the dominant genes that are predictive of the morphological signatures were identified. Specifically, PPARγ has been associated with the invasive stellate morphological phenotype, which corresponds to triple-negative pathobiology. PPARγ has been validated through two supporting biological assays.</p>
</abstract><abstract abstract-type="summary"><title>Author Summary</title>
<p>Cell culture models are an important vehicle for understanding biological processes and evaluation of therapeutic reagents. More importantly, the literature suggests that tumor cells grown in 3D exhibit pronounced drug and radiation resistances that are remarkably similar to that of tumors <italic>in vivo</italic>. Therefore, the needs for quantifying 3D assays continue to grow. In this paper, we develop robust computational methods to integrate morphometric and molecular information for a panel of breast cancer cell lines that are grown in 3D. Specifically, morphometric traits are imaged through microscopy, and then quantified computationally. We then show that these morphometric traits can identify subtypes within this panel of breast cancer cell lines, and that the subtypes are clinically relevant in terms of being ERBB2 positive or triple negative. These subtypes and their representations are then associated with their molecular data to reveal PPARG as an important marker for triple-negative breast cancer. Finally, we design two independent experiments to show the validity of this marker in both 3D cell culture models and human breast cancer tissue.</p>
</abstract><funding-group><funding-statement>This work was supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research (contract DE-AC02-05CH11231); the National Institutes of Health under grants U54 CA112970, CA58207, and CA090788; Susan G. Komen for the Cure (KG091136); and the Avon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="12"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Genome-wide association studies of expression and clinical data have emerged as a powerful methodology for identifying biomarkers of human diseases. While the literature is rich with supervised or unsupervised clustering of genomic information <xref ref-type="bibr" rid="pcbi.1000684-Sharan1">[1]</xref>, methods for studying the relationships between genomic and physiological responses remain limited. This paper contributes to computational protocols for associating morphometric data, collected through phase contrast microscopy, with genome-wide gene expression data. While genome-wide array expression data provide on average a few readouts with structured measurements for an ensemble of colonies, imaging provides one readout per colony and captures the inherent heterogeneity of a population. However, images are composed of unstructured data that require detailed segmentation and representation for the underlying samples. The net result is subtyping, based on computed morphometric features, and a list of associated genes against computed morphometric features for further bioinformatics analysis. This paper also demonstrates that some of the predicted genes are biologically relevant and can be tested through both <italic>in vitro</italic> and <italic>in vivo</italic> models.</p>
<p>Most of the existing methods for clustering (e.g., subtyping) concentrate on either finding subpopulations for a collection of “OMIC” data or identifying groups of genes that can be associated for each subtype. These methods relate a specific signal across measured conditions, which is appropriate for a focused experiment with a small number of conditions, and for partitioning genes into disjoint sets, thus oversimplifying biological systems. More effective clustering methods have focused on bi-clustering <xref ref-type="bibr" rid="pcbi.1000684-Hartigan1">[2]</xref>–<xref ref-type="bibr" rid="pcbi.1000684-Tanay1">[4]</xref>, where bi-clustering aims to find a subset of genes that behave similarly across a subset of conditions. Still, a more effective method is to correlate expression data with known pathways, because pathways represent higher-level biological functions, where the correlation of real value data with known non-numeric pathway data (e.g., KEGG, BRITE) is generally performed through kernel canonical correlation analysis (KCCA) <xref ref-type="bibr" rid="pcbi.1000684-Yamanishi1">[5]</xref>. The original canonical correlation analysis (CCA), developed by Hotelling in 1936, finds projections from two real-value datasets so that those projections have maximum correlations. The kernelized version extends the CCA to non-numerical values. With respect to the understanding of the mechanism of genome-wide regulation and functions, experiments have to be coordinated with the computational requirements to ensure the robustness of any biological conclusion. This is often met by varying or perturbing experimental conditions (e.g., multiple cell lines, different treatment conditions). For example, in a recent paper, microarray data were analyzed with the corresponding physiological responses and clinical metadata <xref ref-type="bibr" rid="pcbi.1000684-Yi1">[6]</xref>. The experiment incorporated NCI-60, a panel of cancer cell lines, that were incubated with Docetaxel, and the impact of the drug was characterized with GI50 (e.g., 50% growth inhibition dose concentration in a 48-hour assay). Subsequently, genes strongly correlated with GI50 were identified.</p>
<p>Experimentally, our method is based on three-dimensional cell culture models, which introduce new computational opportunities, because the assays were imaged with phase contrast microscopy. One primary rationale for designing experiments in 3D cell culture models is that the 3D systems provide a more faithful replication of cell behavior <italic>in vivo</italic> than 2D substrata systems <xref ref-type="bibr" rid="pcbi.1000684-BarcellosHoff1">[7]</xref>,<xref ref-type="bibr" rid="pcbi.1000684-Gudjonsson1">[8]</xref>. Mammary cells cultured on rigid 2D substrata rapidly lose many aspects of their <italic>in vivo</italic> phenotype <xref ref-type="bibr" rid="pcbi.1000684-Emerman1">[9]</xref>, but the use of 3D extracellular matrix cultures (which restore the physiological cell-ECM interactions) allow for a much more faithful replication of <italic>in vivo</italic> phenomena in culture. For example, mammary epithelial cells form polarized acini that vectorially secrete the milk protein, beta-casein, when cultured within a 3D ECM gel <xref ref-type="bibr" rid="pcbi.1000684-BarcellosHoff1">[7]</xref>, and breast cancer cells can be readily distinguished phenotypically from non-malignant breast cells simply by observing their aggressive growth in these assays <xref ref-type="bibr" rid="pcbi.1000684-Petersen1">[10]</xref>. Our experiment consists of 24 cell lines from a panel of non-malignant and malignant breast cell lines. We have developed a computational protocol that quantifies colony structures through segmentation and multidimensional representations. Such a multidimensional representation enables subsequent associations with expression data, as well as with the identification of subpopulations among all the 24 lines.</p>
<p>Our proposed computational protocol consists of five major steps: (i) colony segmentation, (ii) morphological feature extraction, (iii) consensus clustering of morphological features, (iv) differential analysis of morphological clusters with gene expression profiles, and (v) association of cell-line-specific morphological features and their gene expression signatures. These computational steps are shown in <xref ref-type="fig" rid="pcbi-1000684-g001">Figure 1</xref>, where colonies in each phase image are segmented from the background based on texture features. Regions containing individual colonies are extracted and subsequently represented by multidimensional indices, such as size and Zernike moments. Such a representation is translation and rotation invariant. At this point, one path allows genes that are predictive of morphogenesis to be identified. The second path identifies subpopulations through a modified consensus clustering, which finally leads to ranking those genes that differentiate each subpopulation. A few of these genes are druggable targets, and one has been selected for biological validation.</p>
<fig id="pcbi-1000684-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g001</object-id><label>Figure 1</label><caption>
<title>Computational pipeline for differential and association studies between colony morphologies and gene profiles for the panel of breast cancer cell lines cultured in 3D.</title>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g001" xlink:type="simple"/></fig></sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Identification of sub-populations for the panel of cell lines</title>
<p>Our data set includes <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e001" xlink:type="simple"/></inline-formula> phase images from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e002" xlink:type="simple"/></inline-formula> breast cancer cell lines grown in 3D. This data set has produced <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e003" xlink:type="simple"/></inline-formula> colonies from all <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e004" xlink:type="simple"/></inline-formula> cell lines. Following segmentation and feature extraction, each colony is represented with a multidimensional vector as discussed in the <xref ref-type="sec" rid="s4">Methods</xref> section. This is followed by consensus clustering where the number of clusters is varied from 2 to 7 to examine near optimum partitioning.</p>
<p>In order to visualize clustering results, the consensus matrix is traditionally treated as a similarity matrix and reordered using hierarchical clustering. As a result, self similar signatures are placed in close proximity. In this reordered consensus matrix, cell lines with similar morphologies are adjacent to each other, and the darker signal (in the map) reflects improved similarity for the purpose of visualization. Ideally, for a perfect consensus matrix, the displayed heat map should have crisp boundaries. These matrices are generated for a number of clusters, ranging from 2 to 7; the results are shown in <xref ref-type="fig" rid="pcbi-1000684-g002">Figure 2</xref>. The choice of maximum cluster number (e.g., 7) is arbitrary, and the experiment can be repeated if computed consensus matrices and subsequent analysis suggested a larger number of subtypes, but this is biologically less feasible as one is interested in the simplest partition. Consensus clustering assesses stability for the identification of potential subpopulations, and provides visual feedback as a potential component for the decision-making process. For example, for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e005" xlink:type="simple"/></inline-formula>, the consensus matrix has one large and one small block with crisp boundaries; and for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e006" xlink:type="simple"/></inline-formula>, it appears that the large block for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e007" xlink:type="simple"/></inline-formula> has been partitioned into two other blocks. Therefore, a quantitative method for assigning confidence to the selected number of clusters is needed. This is based on computing consensus distribution <xref ref-type="bibr" rid="pcbi.1000684-Monti1">[11]</xref>. By computing a cumulative distribution from consensus matrices and evaluating proportional increase as a function of the number of clusters, the shape of the concentration distribution can be examined. The cumulative distribution function (CDF) is computed from the entire consensus matrix, whose elements are between 0 and 1. The shape of the CDF and its progression as a function of increase in the number of clusters suggest the presence of desirable subpopulations. An earlier paper by <xref ref-type="bibr" rid="pcbi.1000684-Monti1">[11]</xref> evaluated this method with synthetic and real data, proposed a new measure, a “concentration histogram” computed from the change in the shape of the CDF, and suggested that the peak in the concentration histogram corresponds to an estimate of the number of clusters. The concentration histogram of <xref ref-type="fig" rid="pcbi-1000684-g003">Figure 3</xref> suggests that three clusters best represent the desired number of subpopulations. Let's examine identification of subpopulations as the number of clusters increases. At <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e008" xlink:type="simple"/></inline-formula>, one subpopulation contains three cell lines of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e009" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e010" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e011" xlink:type="simple"/></inline-formula>, as shown in <xref ref-type="fig" rid="pcbi-1000684-g004">Figure 4</xref>, where their fingerprints indicate large colony size and complex texture representation displaying aggressive behaviors. At <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e012" xlink:type="simple"/></inline-formula>, the larger block of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e013" xlink:type="simple"/></inline-formula> is approximately partitioned into two subpopulations. One subpopulation corresponds to a round symmetrical morphology expected from non-transformed 3D cell culture models. The other population corresponds to a more aggressive line labeled “grape-like” in the literature <xref ref-type="bibr" rid="pcbi.1000684-Kenny1">[12]</xref>. In summary, the three clusters of round, grape-like, and stellate, shown in <xref ref-type="fig" rid="pcbi-1000684-g005">Figure 5</xref>, suggest the best set of subpopulations, based on morphological similarities. At <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e014" xlink:type="simple"/></inline-formula> spurious clusters (not shown here) are generated that have no clear boundaries.</p>
<fig id="pcbi-1000684-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g002</object-id><label>Figure 2</label><caption>
<title>The consensus matrices for different numbers of clusters <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e015" xlink:type="simple"/></inline-formula> based on morphological representations are shown.</title>
<p>A darker block indicates higher morphological similarity between two cell lines. One can hypothesize that the larger block for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e016" xlink:type="simple"/></inline-formula> has been partitioned into two blocks for <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e017" xlink:type="simple"/></inline-formula>; however, the order is not preserved.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g002" xlink:type="simple"/></fig><fig id="pcbi-1000684-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g003</object-id><label>Figure 3</label><caption>
<title>The CDF and its derivative, computed from the consensus matrix, is used to identify the number of clusters.</title>
<p>(A) CDF for each cluster, and (B) change in CDF as a function of cluster size, indicates that three is the optimum number of sub-populations.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g003" xlink:type="simple"/></fig><fig id="pcbi-1000684-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g004</object-id><label>Figure 4</label><caption>
<title>Three cell lines displaying aggressive phenotypes are discovered with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e018" xlink:type="simple"/></inline-formula>.</title>
<p>All other cell lines are grouped in a different subpopulation.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g004" xlink:type="simple"/></fig><fig id="pcbi-1000684-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g005</object-id><label>Figure 5</label><caption>
<title>Three subpopulations of the 24 breast cancer cell lines grown in three-dimensional cell culture assay are revealed through consensus clustering.</title>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g005" xlink:type="simple"/></fig></sec><sec id="s2b">
<title>Molecular predictors of phenotypes</title>
<p>Examining the association between phenotypic signatures and expression data is an exploratory step, which requires molecular diversity in the data set to avoid homogeneity. Two distinct approaches are applied, where each approach brings a unique view to the data. (I) In the first approach, expression data associated with each cell line are grouped into their corresponding morphological cluster. As a result, genes that best discriminate between different clusters can be ranked according to their differential strength. (II) In the second approach, genes are ranked against each morphological feature through linear or nonlinear regression analysis. As a result, molecular predictors for positive or negative correlation can be inferred.</p>
<sec id="s2b1">
<title>Molecular predictors of morphological subpopulations</title>
<p>In this case, expression data associated with each cell line are assigned to their own morphological cluster. The objective is to identify genes that best discriminate each morphological cluster. Accordingly, genes are ranked for three classification experiments, where each experiment is one class versus the other two. The main objective is to identify those genes that best predict round, grape-like, and stellate clusters. <xref ref-type="table" rid="pcbi-1000684-t001">Table 1</xref> lists those genes, with false discovery rate (FDR) of less than 0.001, that best discriminate stellate versus the other two classes. Similar experiments for round versus stellate and grape-like or grape-like versus stellate and round did not reveal any gene with an FDR of less than <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e019" xlink:type="simple"/></inline-formula>. Hence, results are not reported here.</p>
<table-wrap id="pcbi-1000684-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.t001</object-id><label>Table 1</label><caption>
<title>Best genes for predicting the stellate cluster based on moderated t-statistic (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e020" xlink:type="simple"/></inline-formula>).</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000684-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.t001" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Gene symbol</td>
<td align="left" colspan="1" rowspan="1">Gene description</td>
<td align="left" colspan="1" rowspan="1">p-value</td>
<td align="left" colspan="1" rowspan="1">FDR</td>
<td align="left" colspan="1" rowspan="1">Expression level</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">PPARG</td>
<td align="left" colspan="1" rowspan="1">peroxisome proliferator-activated receptor <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e021" xlink:type="simple"/></inline-formula></td>
<td align="left" colspan="1" rowspan="1">9.13E-15</td>
<td align="left" colspan="1" rowspan="1">9.54E-11</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PARG</td>
<td align="left" colspan="1" rowspan="1">poly (ADP-ribose) glycohydrolase</td>
<td align="left" colspan="1" rowspan="1">4.31E-09</td>
<td align="left" colspan="1" rowspan="1">1.73E-05</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FADS1///FADS3</td>
<td align="left" colspan="1" rowspan="1">fatty acid desaturase 1 /// fatty acid desaturase 3</td>
<td align="left" colspan="1" rowspan="1">7.20E-09</td>
<td align="left" colspan="1" rowspan="1">1.73E-05</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PALM2-AKAP2</td>
<td align="left" colspan="1" rowspan="1">paralemmin 2 - A kinase (PRKA) anchor protein 2</td>
<td align="left" colspan="1" rowspan="1">8.23E-09</td>
<td align="left" colspan="1" rowspan="1">1.73E-05</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FADS3</td>
<td align="left" colspan="1" rowspan="1">fatty acid desaturase 3</td>
<td align="left" colspan="1" rowspan="1">8.66E-09</td>
<td align="left" colspan="1" rowspan="1">1.73E-05</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TFPI</td>
<td align="left" colspan="1" rowspan="1">tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)</td>
<td align="left" colspan="1" rowspan="1">1.08E-08</td>
<td align="left" colspan="1" rowspan="1">1.73E-05</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AKAP2/// PALM2/// PALM2-AKAP2</td>
<td align="left" colspan="1" rowspan="1">A kinase (PRKA) anchor protein 2 /// paralemmin 2 /// PALM2-AKAP2</td>
<td align="left" colspan="1" rowspan="1">1.16E-08</td>
<td align="left" colspan="1" rowspan="1">1.73E-05</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LEPRE1</td>
<td align="left" colspan="1" rowspan="1">leucine proline-enriched proteoglycan (leprecan) 1</td>
<td align="left" colspan="1" rowspan="1">1.48E-07</td>
<td align="left" colspan="1" rowspan="1">1.80E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DAB2</td>
<td align="left" colspan="1" rowspan="1">disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)</td>
<td align="left" colspan="1" rowspan="1">1.74E-07</td>
<td align="left" colspan="1" rowspan="1">1.80E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VCL</td>
<td align="left" colspan="1" rowspan="1">vinculin</td>
<td align="left" colspan="1" rowspan="1">1.76E-07</td>
<td align="left" colspan="1" rowspan="1">1.80E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PALM</td>
<td align="left" colspan="1" rowspan="1">paralemmin</td>
<td align="left" colspan="1" rowspan="1">1.90E-07</td>
<td align="left" colspan="1" rowspan="1">1.80E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PTGER4</td>
<td align="left" colspan="1" rowspan="1">prostaglandin E receptor 4 (subtype EP4)</td>
<td align="left" colspan="1" rowspan="1">2.87E-07</td>
<td align="left" colspan="1" rowspan="1">2.50E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CLCN6</td>
<td align="left" colspan="1" rowspan="1">chloride channel 6</td>
<td align="left" colspan="1" rowspan="1">3.84E-07</td>
<td align="left" colspan="1" rowspan="1">3.09E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DCBLD2</td>
<td align="left" colspan="1" rowspan="1">discoidin, CUB and LCCL domain containing 2</td>
<td align="left" colspan="1" rowspan="1">5.36E-07</td>
<td align="left" colspan="1" rowspan="1">4.00E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FSTL1</td>
<td align="left" colspan="1" rowspan="1">follistatin-like 1</td>
<td align="left" colspan="1" rowspan="1">9.66E-07</td>
<td align="left" colspan="1" rowspan="1">6.73E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FST</td>
<td align="left" colspan="1" rowspan="1">follistatin</td>
<td align="left" colspan="1" rowspan="1">1.39E-06</td>
<td align="left" colspan="1" rowspan="1">9.10E-04</td>
<td align="left" colspan="1" rowspan="1">+</td>
</tr>
</tbody>
</table></alternatives></table-wrap></sec><sec id="s2b2">
<title>Molecular predictors of morphological features</title>
<p>Both linear and nonlinear prediction models are explored for molecular predictors of morphological features. Although the simplicity of a linear relationship is quite desirable, many naturally occurring biological interactions are nonlinear. The analysis pipeline has three components: (i) predicting genes that positively correlate with a specific morphological features, (ii) predicting genes that negatively correlate with the same morphological features, and (iii) validating data with a functional analysis. In steps (i) and (ii), a correlation coefficient is transformed into a p-value through permutation analysis.</p>
<p><xref ref-type="table" rid="pcbi-1000684-t002">Tables 2</xref> and <xref ref-type="table" rid="pcbi-1000684-t003">3</xref> summarize the top genes that best predict the size of the colony for positive and negative correlation, respectively, with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e022" xlink:type="simple"/></inline-formula>.</p>
<table-wrap id="pcbi-1000684-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.t002</object-id><label>Table 2</label><caption>
<title>Genes that best predict the size of the colony in terms of positive logistic relationship (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e023" xlink:type="simple"/></inline-formula>).</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000684-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.t002" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Gene symbol</td>
<td align="left" colspan="1" rowspan="1">Gene description</td>
<td align="left" colspan="1" rowspan="1"><inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e024" xlink:type="simple"/></inline-formula></td>
<td align="left" colspan="1" rowspan="1">p-value</td>
<td align="left" colspan="1" rowspan="1">FDR</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">PPARG</td>
<td align="left" colspan="1" rowspan="1">peroxisome proliferator-activated receptor <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e025" xlink:type="simple"/></inline-formula></td>
<td align="left" colspan="1" rowspan="1">0.8667</td>
<td align="left" colspan="1" rowspan="1">1.82E-07</td>
<td align="left" colspan="1" rowspan="1">2.18E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LPIN2</td>
<td align="left" colspan="1" rowspan="1">lipin 2</td>
<td align="left" colspan="1" rowspan="1">0.8450</td>
<td align="left" colspan="1" rowspan="1">7.49E-07</td>
<td align="left" colspan="1" rowspan="1">4.48E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">VCL</td>
<td align="left" colspan="1" rowspan="1">vinculin</td>
<td align="left" colspan="1" rowspan="1">0.8145</td>
<td align="left" colspan="1" rowspan="1">3.95E-06</td>
<td align="left" colspan="1" rowspan="1">1.18E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">INSIG1</td>
<td align="left" colspan="1" rowspan="1">insulin induced gene 1</td>
<td align="left" colspan="1" rowspan="1">0.7932</td>
<td align="left" colspan="1" rowspan="1">1.06E-05</td>
<td align="left" colspan="1" rowspan="1">1.41E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">APBA2</td>
<td align="left" colspan="1" rowspan="1">amyloid beta (A4) precursor protein-binding, family A, member 2 (X11-like)</td>
<td align="left" colspan="1" rowspan="1">0.7884</td>
<td align="left" colspan="1" rowspan="1">1.31E-05</td>
<td align="left" colspan="1" rowspan="1">1.42E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CDH11</td>
<td align="left" colspan="1" rowspan="1">cadherin 11, type 2, OB-cadherin (osteoblast)</td>
<td align="left" colspan="1" rowspan="1">0.7860</td>
<td align="left" colspan="1" rowspan="1">1.45E-05</td>
<td align="left" colspan="1" rowspan="1">1.45E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DLC1</td>
<td align="left" colspan="1" rowspan="1">deleted in liver cancer 1</td>
<td align="left" colspan="1" rowspan="1">0.7890</td>
<td align="left" colspan="1" rowspan="1">1.28E-05</td>
<td align="left" colspan="1" rowspan="1">1.53E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PRR3</td>
<td align="left" colspan="1" rowspan="1">proline rich 3</td>
<td align="left" colspan="1" rowspan="1">0.7940</td>
<td align="left" colspan="1" rowspan="1">1.03E-05</td>
<td align="left" colspan="1" rowspan="1">1.54E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BCAT1</td>
<td align="left" colspan="1" rowspan="1">branched chain aminotransferase 1, cytosolic</td>
<td align="left" colspan="1" rowspan="1">0.7788</td>
<td align="left" colspan="1" rowspan="1">1.96E-05</td>
<td align="left" colspan="1" rowspan="1">1.67E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AXL</td>
<td align="left" colspan="1" rowspan="1">AXL receptor tyrosine kinase</td>
<td align="left" colspan="1" rowspan="1">0.7697</td>
<td align="left" colspan="1" rowspan="1">2.81E-05</td>
<td align="left" colspan="1" rowspan="1">1.87E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RFTN1</td>
<td align="left" colspan="1" rowspan="1">raftlin, lipid raft linker 1</td>
<td align="left" colspan="1" rowspan="1">0.796</td>
<td align="left" colspan="1" rowspan="1">9.41E-06</td>
<td align="left" colspan="1" rowspan="1">1.88E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TMEM22</td>
<td align="left" colspan="1" rowspan="1">transmembrane protein 22</td>
<td align="left" colspan="1" rowspan="1">0.7705</td>
<td align="left" colspan="1" rowspan="1">2.73E-05</td>
<td align="left" colspan="1" rowspan="1">1.92E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">AP1S2</td>
<td align="left" colspan="1" rowspan="1">adaptor-related protein complex 1, sigma 2 subunit</td>
<td align="left" colspan="1" rowspan="1">0.7718</td>
<td align="left" colspan="1" rowspan="1">2.59E-05</td>
<td align="left" colspan="1" rowspan="1">1.93E-02</td>
</tr>
</tbody>
</table></alternatives></table-wrap><table-wrap id="pcbi-1000684-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.t003</object-id><label>Table 3</label><caption>
<title>Genes that best predict the size of the colony in terms of negative logistic relationship (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e026" xlink:type="simple"/></inline-formula>).</title>
</caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1000684-t003-3" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.t003" xlink:type="simple"/><table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" colspan="1" rowspan="1">Gene symbol</td>
<td align="left" colspan="1" rowspan="1">Gene description</td>
<td align="left" colspan="1" rowspan="1"><inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e027" xlink:type="simple"/></inline-formula></td>
<td align="left" colspan="1" rowspan="1">p-value</td>
<td align="left" colspan="1" rowspan="1">FDR</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">F11R</td>
<td align="left" colspan="1" rowspan="1">F11 receptor</td>
<td align="left" colspan="1" rowspan="1">−0.7162</td>
<td align="left" colspan="1" rowspan="1">1.78E-04</td>
<td align="left" colspan="1" rowspan="1">2.18E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ARHGEF5</td>
<td align="left" colspan="1" rowspan="1">Rho guanine nucleotide exchange factor (GEF) 5</td>
<td align="left" colspan="1" rowspan="1">−0.7078</td>
<td align="left" colspan="1" rowspan="1">2.29E-04</td>
<td align="left" colspan="1" rowspan="1">4.48E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ITPKC</td>
<td align="left" colspan="1" rowspan="1">inositol 1,4,5-trisphosphate 3-kinase C</td>
<td align="left" colspan="1" rowspan="1">−0.7019</td>
<td align="left" colspan="1" rowspan="1">2.72E-04</td>
<td align="left" colspan="1" rowspan="1">9.50E-03</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DSP</td>
<td align="left" colspan="1" rowspan="1">desmoplakin</td>
<td align="left" colspan="1" rowspan="1">−0.6997</td>
<td align="left" colspan="1" rowspan="1">2.90E-04</td>
<td align="left" colspan="1" rowspan="1">1.18E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CTAGE4</td>
<td align="left" colspan="1" rowspan="1">CTAGE family, member 4</td>
<td align="left" colspan="1" rowspan="1">−0.6692</td>
<td align="left" colspan="1" rowspan="1">6.60E-04</td>
<td align="left" colspan="1" rowspan="1">1.41E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MKRN1</td>
<td align="left" colspan="1" rowspan="1">makorin ring finger protein 1</td>
<td align="left" colspan="1" rowspan="1">−0.6639</td>
<td align="left" colspan="1" rowspan="1">7.55E-04</td>
<td align="left" colspan="1" rowspan="1">1.42E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HOXC13</td>
<td align="left" colspan="1" rowspan="1">homeobox C13</td>
<td align="left" colspan="1" rowspan="1">−0.6662</td>
<td align="left" colspan="1" rowspan="1">7.12E-04</td>
<td align="left" colspan="1" rowspan="1">1.53E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SRCAP</td>
<td align="left" colspan="1" rowspan="1">Snf2-related CREBBP activator protein</td>
<td align="left" colspan="1" rowspan="1">−0.6709</td>
<td align="left" colspan="1" rowspan="1">6.32E-04</td>
<td align="left" colspan="1" rowspan="1">1.54E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PTPLB</td>
<td align="left" colspan="1" rowspan="1">protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b</td>
<td align="left" colspan="1" rowspan="1">−0.6567</td>
<td align="left" colspan="1" rowspan="1">9.02E-04</td>
<td align="left" colspan="1" rowspan="1">1.63E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">LIMK2</td>
<td align="left" colspan="1" rowspan="1">LIM domain kinase 2</td>
<td align="left" colspan="1" rowspan="1">−0.647</td>
<td align="left" colspan="1" rowspan="1">1.14E-03</td>
<td align="left" colspan="1" rowspan="1">1.67E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">RARG</td>
<td align="left" colspan="1" rowspan="1">retinoic acid receptor, gamma</td>
<td align="left" colspan="1" rowspan="1">−0.6712</td>
<td align="left" colspan="1" rowspan="1">6.26E-04</td>
<td align="left" colspan="1" rowspan="1">1.72E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">TNK1</td>
<td align="left" colspan="1" rowspan="1">tyrosine kinase, non-receptor, 1</td>
<td align="left" colspan="1" rowspan="1">−0.6415</td>
<td align="left" colspan="1" rowspan="1">1.29E-03</td>
<td align="left" colspan="1" rowspan="1">1.87E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MAPRE3</td>
<td align="left" colspan="1" rowspan="1">microtubule-associated protein, RP/EB family, member 3</td>
<td align="left" colspan="1" rowspan="1">−0.6719</td>
<td align="left" colspan="1" rowspan="1">6.15E-04</td>
<td align="left" colspan="1" rowspan="1">1.88E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OVOL2</td>
<td align="left" colspan="1" rowspan="1">ovo-like 2 (Drosophila)</td>
<td align="left" colspan="1" rowspan="1">−0.6419</td>
<td align="left" colspan="1" rowspan="1">1.28E-03</td>
<td align="left" colspan="1" rowspan="1">1.92E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CD79A</td>
<td align="left" colspan="1" rowspan="1">CD79a molecule, immunoglobulin-associated alpha</td>
<td align="left" colspan="1" rowspan="1">−0.6422</td>
<td align="left" colspan="1" rowspan="1">1.27E-03</td>
<td align="left" colspan="1" rowspan="1">1.93E-02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EPHB3</td>
<td align="left" colspan="1" rowspan="1">EPH receptor B3</td>
<td align="left" colspan="1" rowspan="1">−0.6462</td>
<td align="left" colspan="1" rowspan="1">1.16E-03</td>
<td align="left" colspan="1" rowspan="1">1.96E-02</td>
</tr>
</tbody>
</table></alternatives></table-wrap></sec></sec></sec><sec id="s3">
<title>Discussion</title>
<sec id="s3a">
<title>Morphological subtyping</title>
<p>We compare clustering results with those from interactive methods and provide an interpretation of the morphological similarities based on their known molecular predictors. In an earlier paper <xref ref-type="bibr" rid="pcbi.1000684-Kenny1">[12]</xref>, an extended set of similar data was analyzed manually, and four subpopulations – round, mass, grape-like, and stellate– were labeled. However, manual analysis of individual colonies is extremely laborious and prone to user bias. Thus, we have developed a computational protocol to identify subpopulations. In our analysis, round and mass clusters are grouped together, since they have no morphological differences when imaged through phase contrast microscopy. However, the above two phenotypes can be differentiated from each other under fluorescence microscopy. The difference is due to the degree of internal organization in these phenotypes. Round colonies tend to have cells arranged in an approximately radial symmetry, while mass colonies are significantly more disorganized. This can only be visualized at higher magnification and confocal microscopy; however, these data have not been included in our analysis. Otherwise, <xref ref-type="fig" rid="pcbi-1000684-g005">Figure 5</xref> is consistent with <xref ref-type="table" rid="pcbi-1000684-t001">Table 1</xref> in <xref ref-type="bibr" rid="pcbi.1000684-Kenny1">[12]</xref>.</p>
<p>Results indicate that 8 out of 9 cell lines from the grape-like subpopulation express high levels of ERBB2 as a result of amplification of this gene <xref ref-type="bibr" rid="pcbi.1000684-Kenny1">[12]</xref>, which is differentially expressed between grape-like and round/stellate cell lines with p-value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e028" xlink:type="simple"/></inline-formula>. The exception is MDA-MB-468, which has a significant amplification of EGFR. Collectively, these data suggest that the deregulation of signaling through the EGFR/ERBB2 signaling axis may make a strong contribution to the grape-like morphology in culture. The stellate colonies are all negative for estrogen receptors, progesterone receptors, and HER2, a phenotype termed triple negative by pathologists and characterized by a very poor prognosis in cancer patients, as this type of tumor is highly invasive <xref ref-type="bibr" rid="pcbi.1000684-Rakha1">[13]</xref>. The invasive nature of the colonies formed by these cells in the 3D culture assay may be reflective of the <italic>in vivo</italic> invasive capacity of these tumor cells.</p>
</sec><sec id="s3b">
<title>Molecular predictors of phenotypic response</title>
<p>Previous results for molecular predictors of morphological subpopulations indicate that the gene expression profiles of stellate colonies are the most distinct from the other two morphological classes, which is consistent with their invasive mesenchymal phenotype compared to the more epithelial colonies formed by round and grape-like cells. A brief description of the molecular predictors, listed in the previous tables, and their relevance is provided below.</p>
<p>Consistent with the mesenchymal phenotype of these cells, PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e029" xlink:type="simple"/></inline-formula>, the top gene on this list (<xref ref-type="table" rid="pcbi-1000684-t001">Table 1</xref>), has been reported to be a potent inducer of EMT in intestinal epithelial cells <xref ref-type="bibr" rid="pcbi.1000684-Chen1">[14]</xref>. Similarly, DAB2 has been reported to be required for TGF-beta induced EMT <xref ref-type="bibr" rid="pcbi.1000684-Prunier1">[15]</xref>. PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e030" xlink:type="simple"/></inline-formula> is a nuclear receptor protein, and functions as a transcription factor. It is (i) regulated by thiazolidinediones (TZD), a class of oral anti-diabetic drugs, (ii) involved in proliferation and differentiation <xref ref-type="bibr" rid="pcbi.1000684-Chen1">[14]</xref>, and (iii) shown to be highly expressed in metastasized human breast tissue <xref ref-type="bibr" rid="pcbi.1000684-Naik1">[16]</xref>. FADS1 is involved in the synthesis of highly unsaturated fatty acids such as arachidonic acid <xref ref-type="bibr" rid="pcbi.1000684-Nakamura1">[17]</xref>, which (i) are metabolites that activate PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e031" xlink:type="simple"/></inline-formula> <xref ref-type="bibr" rid="pcbi.1000684-Wang1">[18]</xref>, and (ii) can also be converted to prostaglandins, by cyclooxygenases. The Prostaglandin EP4 receptor (PTGER4) was correlated highly with the stellate phenotype and has been implicated in migration of MDA-MB-231 cells <italic>in vitro</italic> <xref ref-type="bibr" rid="pcbi.1000684-Timoshenko1">[19]</xref>. Inhibition of EP4 has been demonstrated to have anti-metastatic effects in preclinical mouse models <xref ref-type="bibr" rid="pcbi.1000684-Ma1">[20]</xref>. Poly(ADP-Ribose) glycohydrolase (PARG) was also highly expressed in stellate cells. PARG and PARP have been reported to localize to sites of DNA damage (reviewed in <xref ref-type="bibr" rid="pcbi.1000684-Miwa1">[21]</xref>) and, intriguingly, mice deficient in PARG are hypersensitive to both <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e032" xlink:type="simple"/></inline-formula>-irradiation and alkylating agents <xref ref-type="bibr" rid="pcbi.1000684-Cortes1">[22]</xref>, suggesting that high levels of PARG may contribute to resistance to DNA-damaging agents in cancer therapy. Stellate cell lines also expressed relatively high levels of Tissue Factor Pathway Inhibitor (TFPI), which is found at high levels in patients with advanced cancer, yet has been proposed to have anti-angiogenic and anti-metastatic functions <xref ref-type="bibr" rid="pcbi.1000684-Amirkhosravi1">[23]</xref>. Multiple probes corresponding to PALM2/AKAP2, which are alternative splicing variants of the same gene <xref ref-type="bibr" rid="pcbi.1000684-Hu1">[24]</xref>, were upregulated in stellate cells. Although the function of PALM2 is not known, PALM1 has been implicated in the filopodia and spine formation during dendritic branching <xref ref-type="bibr" rid="pcbi.1000684-Arstikaitis1">[25]</xref>, so it is tempting to speculate that PALM2 may contribute to the production of the stellate processes seen in these cell lines. DCBLD2 is highly expressed by metastatic cells in culture, and in lung cancer tissue at both primary and metastatic sites <xref ref-type="bibr" rid="pcbi.1000684-Koshikawa1">[26]</xref>.</p>
<p>PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e033" xlink:type="simple"/></inline-formula> was also the gene most strongly associated with colony size (<xref ref-type="table" rid="pcbi-1000684-t002">Table 2</xref>). Also highly associated was INSIG1, a PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e034" xlink:type="simple"/></inline-formula> target gene <xref ref-type="bibr" rid="pcbi.1000684-KastWoelbern1">[27]</xref>, suggesting that the upregulated PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e035" xlink:type="simple"/></inline-formula> is functionally active in these cells. Axl kinase levels also positively correlated with colony size. Consistent with this, Axl activity has been shown to augment MDA-MB-231 xenograft growth in mammary fat pads and subsequent lung metastasis <xref ref-type="bibr" rid="pcbi.1000684-Li1">[28]</xref>. Of the other genes associated with colony size, TMEM22 has been reported to play a role in cell proliferation in renal cell carcinoma <xref ref-type="bibr" rid="pcbi.1000684-Dobashi1">[29]</xref>.</p>
<p>Among the genes negatively associated with colony size (<xref ref-type="table" rid="pcbi-1000684-t003">Table 3</xref>), there are several tumor suppressor genes with roles in normal mammary epithelium. F11R encodes the Junction Adhesion Molecule A (JAM-A) gene. This gene is highly expressed in normal mammary epithelium, but down-regulated in invasive breast cancer cells <xref ref-type="bibr" rid="pcbi.1000684-Naik1">[16]</xref>. TNK1, OVOL2, and EPHB3 are candidate tumor suppressor genes. Deletion of TNK1 in mice results in spontaneous tumorigenesis in several tissues <xref ref-type="bibr" rid="pcbi.1000684-Hoare1">[30]</xref>. OVOL2 is a suppressor of c-MYC, and OVOL2-depletion by siRNA promotes cell proliferation <xref ref-type="bibr" rid="pcbi.1000684-Wells1">[31]</xref>. Overexpression of EPHB3 in colorectal cancer cells inhibited proliferation in monolayer culture and growth in both soft agar assays and as xenografts <xref ref-type="bibr" rid="pcbi.1000684-Chiu1">[32]</xref>.</p>
</sec><sec id="s3c">
<title>Validation</title>
<p>Our validation strategy has two supporting components of <italic>in vitro</italic> and <italic>in vivo</italic> experiments focusing on PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e036" xlink:type="simple"/></inline-formula>, since it is a druggable target. PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e037" xlink:type="simple"/></inline-formula> is a hub for lipid metabolism and has been suggested as a therapeutic strategy for epithelial tumor types <xref ref-type="bibr" rid="pcbi.1000684-Gill1">[33]</xref>.</p>
<p><xref ref-type="fig" rid="pcbi-1000684-g006">Figure 6</xref> shows an example of vehicle control, treatment with PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e038" xlink:type="simple"/></inline-formula> inhibitor, and reduction in the proliferation rate, as measured by the rate of metabolism of WST1. This result is consistent with earlier reports in 2D culture <xref ref-type="bibr" rid="pcbi.1000684-Seargent1">[34]</xref> that GW9662 inhibited cell growth and the survival of MDA-MB-231.</p>
<fig id="pcbi-1000684-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g006</object-id><label>Figure 6</label><caption>
<title>Treatment of a MDA-MB-231 with a PPARG-inhibitor indicates reduction in the proliferation rate.</title>
<p>(A) untreated line, (B) treatment with Gw-9662, and (C) proliferation index. The proliferation index was determined by incubating cultures with cell proliferation analysis reagent, WST1, on Day 5.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g006" xlink:type="simple"/></fig>
<p>In the second case, localization of PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e039" xlink:type="simple"/></inline-formula> was analyzed by immunohistochemistry in normal breast tissue and in sections from triple-negative breast tumors. Other researchers <xref ref-type="bibr" rid="pcbi.1000684-Suzuki1">[35]</xref> have examined PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e040" xlink:type="simple"/></inline-formula> expression in a large cohort of breast tumors, although they did not specifically analyze triple-negative tumors in their studies. Results are shown in <xref ref-type="fig" rid="pcbi-1000684-g007">Figure 7</xref>, and details are included in <xref ref-type="supplementary-material" rid="pcbi.1000684.s001">Text S1</xref>.</p>
<fig id="pcbi-1000684-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g007</object-id><label>Figure 7</label><caption>
<title>PPARG is expressed in triple negative human breast cancer tissue.</title>
<p>(A–B) Localization of PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e041" xlink:type="simple"/></inline-formula> in normal and triple negative of human mammary tissue sections indicates that (i) in normal tissue, localization is apical and unbound to the nuclear regions, and (ii) in triple negative tissue, localization is nuclear-bound and heterogeneous. (C–D) Quantitative analysis on a cell-by-cell basis indicates that PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e042" xlink:type="simple"/></inline-formula> (i) is upregulated in triple negative patients, and (ii) has a heterogeneous distribution.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g007" xlink:type="simple"/></fig></sec></sec><sec id="s4" sec-type="methods">
<title>Methods</title>
<sec id="s4a">
<title>Cell lines and their culture conditions in 3D</title>
<p>A panel of 24 breast cancer cell lines was cultured in 3D <xref ref-type="bibr" rid="pcbi.1000684-Kenny1">[12]</xref>. HMT-3522 S1 (S1) and HMT-3522 T4-2 (T4) mammary epithelial cells were maintained on tissue culture plastic <xref ref-type="bibr" rid="pcbi.1000684-Briand1">[36]</xref>–<xref ref-type="bibr" rid="pcbi.1000684-Weaver1">[39]</xref>. The following human breast cancer cell lines were maintained on tissue culture plastic in the following manners: CAMA-1, Hs578T, MCF-7, MDA-MB- 231, MDA-MB-361, MDA-MB-415, MDA-MB-436, MDA-MB-453, MDA-MB-468, MPE-600, SK-BR-3, and UACC-812 were propagated in DMEM/H-21 (Invitrogen) with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e043" xlink:type="simple"/></inline-formula> fetal bovine serum (Gemini); AU565, BT-474, BT-483, BT-549, HCC70, HCC1569, T-47D, ZR-75-1, and ZR-75-B were propagated in RPMI 1640 (Invitrogen) with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e044" xlink:type="simple"/></inline-formula> fetal bovine serum; and MCF-12A was propagated in DMEM/F-12 (Invitrogen) with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e045" xlink:type="simple"/></inline-formula> ng/ml insulin, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e046" xlink:type="simple"/></inline-formula> ng/ml cholera toxin, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e047" xlink:type="simple"/></inline-formula> ng/ml hydrocortisone, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e048" xlink:type="simple"/></inline-formula> ng/ml EGF (Sigma), and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e049" xlink:type="simple"/></inline-formula> fetal bovine serum. Three-dimensional laminin-rich extracellular matrix (3D lrECM) on-top cultures <xref ref-type="bibr" rid="pcbi.1000684-Lee1">[40]</xref> were prepared by trypsinization of cells from tissue culture plastic, seeding of single cells on top of a thin gel of Engelbreth-Holm-Swarm (EHS) tumor extract (Matrigel: BD Biosciences; Cultrex BME: Trevigen), and the addition of a medium containing <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e050" xlink:type="simple"/></inline-formula> EHS. Cell lines with round 3D morphology were seeded at a density of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e051" xlink:type="simple"/></inline-formula> cells per <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e052" xlink:type="simple"/></inline-formula>; cell lines with stellate 3D morphology were seeded at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e053" xlink:type="simple"/></inline-formula> cells per <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e054" xlink:type="simple"/></inline-formula>; and all other cell lines were seeded at <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e055" xlink:type="simple"/></inline-formula> cells per <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e056" xlink:type="simple"/></inline-formula>. All 3D lrECM cell cultures were maintained in H14 medium with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e057" xlink:type="simple"/></inline-formula> fetal bovine serum, with the exception of S1 and T4, which were maintained in their propagation medium, for 4 days with media change every 2 days.</p>
</sec><sec id="s4b">
<title>Image acquisition and RNA collection</title>
<p>(I) Cell lines were grown in 3D, and cultured colonies were imaged with phase contrast microscopy at 10×. Colonies were isolated from 3D cultures by dissolution in PBS/EDTA <xref ref-type="bibr" rid="pcbi.1000684-Lee1">[40]</xref>. (II) Purified total cellular RNA was extracted using an RNeasy Mini Kit with on-column DNase digestion (Qiagen). RNA was quantified by measuring optical density at A260, and quality was verified by agarose gel electrophoresis. Affymetrix microarray analysis was performed using either the Affymetrix high-density oligonucleotide array human HG-U133A chip cartridge system or the Affymetrix High Throughput Array (HTA) GeneChip system, in which HG-U133A chips were mounted on pegs arranged in a 96-well format. Robust multi-array analysis (RMA) was performed to normalize data collected from different samples. The details can be found in an earlier paper <xref ref-type="bibr" rid="pcbi.1000684-Kenny1">[12]</xref>. For gene expression data, the sample size is small, and on the average, there are two samples per cell line. Replicates are either averaged or their medians are selected for representation. On the other hand, the sample size for image-based data is quite large, on the order of thousands.</p>
</sec><sec id="s4c">
<title>Multidimensional profiling of colony morphologies</title>
<p>The first step in multivariate profiling is the segmentation of a colony from its immediate background. Segmentation enables the feature-based representation of each colony for subsequent clustering and correlation analysis with expression data.</p>
<sec id="s4c1">
<title>Colony segmentation</title>
<p>A robust method for delineating samples imaged through phase contrast microscopy is through a bank of gradient feature detectors at different scales and orientations. The main advantage of a multiscale approach is that proper scale (e.g., neighborhood support for computation of the derivative and its orientation) is not known in advance. One immediate consequence of this procedure is that ambiguities due to single-point operations (e.g., thresholding) can be overcome in favor of a more robust process. One implementation of multiscale derivative computation is through a bank of Gabor filters. From the perspective of a mammalian visual system, Gabor filters have the same characteristic as cells in the visual cortex. From a computational perspective, these filters have been shown to have an optimal localization in both spatial and frequency domains <xref ref-type="bibr" rid="pcbi.1000684-Daugman1">[41]</xref>, and the filter bank can be designed so that the overlap between individual filters is minimized.</p>
<p>In our implementation, rotation-invariant Gabor features are used to characterize image gradient information at different scales <xref ref-type="bibr" rid="pcbi.1000684-Han1">[42]</xref>. A 2D Gabor function <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e058" xlink:type="simple"/></inline-formula> and its Fourier transform <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e059" xlink:type="simple"/></inline-formula> can be expressed as:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e060" xlink:type="simple"/><label>(1)</label></disp-formula>and<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e061" xlink:type="simple"/><label>(2)</label></disp-formula>respectively, where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e062" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e063" xlink:type="simple"/></inline-formula>. A set of Gabor functions can be generated by rotating and scaling <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e064" xlink:type="simple"/></inline-formula>. Let <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e065" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e066" xlink:type="simple"/></inline-formula> be scaling and rotation parameters, respectively. Then <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e067" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e068" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e069" xlink:type="simple"/></inline-formula>. To reduce the redundancy in the filtered images, the filter parameters are chosen to ensure that the adjacent half-peak magnitude iso-curves are tangential to each other in the frequency domain. For example, <xref ref-type="fig" rid="pcbi-1000684-g008">Fig. 8</xref> shows iso-curves of half-peak magnitude at six different orientations and four scales (e.g., size) <xref ref-type="bibr" rid="pcbi.1000684-Manjunath1">[43]</xref>.</p>
<fig id="pcbi-1000684-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g008</object-id><label>Figure 8</label><caption>
<title>The elliptical contours indicate the half-peak magnitude iso-curves of the Gabor filters, in the frequency domain, at 6 orientations and 4 scales.</title>
<p>At each scale, mean filter response is invariant to rotation.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g008" xlink:type="simple"/></fig>
<p>By accumulating all rotated filters (e.g., integration over <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e070" xlink:type="simple"/></inline-formula>), at each scale (e.g., every <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e071" xlink:type="simple"/></inline-formula>), a series of rotation-invariant filters,<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e072" xlink:type="simple"/><label>(3)</label></disp-formula>whose entire half-plane frequency spectrum is shown in each dotted region of <xref ref-type="fig" rid="pcbi-1000684-g008">Figure 8</xref>, are obtained. Thus, the filtered images represent rotation-invariant texture properties of the input image, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e073" xlink:type="simple"/></inline-formula>,<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e074" xlink:type="simple"/><label>(4)</label></disp-formula>where each pixel is represented by an <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e075" xlink:type="simple"/></inline-formula>-dimensional texture feature vector. Subsequently, the K-means method is used to delineate background and foreground pixels. The initial condition is set at the lowest and highest values of the filter response. The end result is a binary representation of the original image corresponding to one of the two classes; examples are shown in <xref ref-type="fig" rid="pcbi-1000684-g009">Figure 9</xref>.</p>
<fig id="pcbi-1000684-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1000684.g009</object-id><label>Figure 9</label><caption>
<title>Regions associated with the multicellular colonies are differentiated through proposed computational method.</title>
<p>(a)(c) original images of two types of colonies with contrast reversal (e.g., dark regions in the bottom row versus bright regions in the top row), and (b)(d) the corresponding segmented results. Segmentation is feasible as a result of the Gabor filter bank that encodes oriented texture features.</p>
</caption><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.g009" xlink:type="simple"/></fig></sec><sec id="s4c2">
<title>Phenotypic representation</title>
<p>Following segmentation, morphometric properties of each colony are represented for subtyping or clustering. However, such a representation has to be invariant to rotation and translation (e.g., the area of a colony has such a property), since orientation of a colony cannot be predicted a priori <xref ref-type="bibr" rid="pcbi.1000684-Teague1">[44]</xref>,<xref ref-type="bibr" rid="pcbi.1000684-Belkasim1">[45]</xref>. Here, we opted to use Zernike moments, which have been widely used for representation, and are shown to outperform other moment invariants in shape-based classification and recognition <xref ref-type="bibr" rid="pcbi.1000684-Belkasim1">[45]</xref>. In our system, the first <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e076" xlink:type="simple"/></inline-formula> orders of moments are computed from the image gradient, which is invariant to contrast reversal and shading, and then normalized to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e077" xlink:type="simple"/></inline-formula>. Overall, each segmented colony is represented by a 33-dimensional vector. Zernike moments of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e078" xlink:type="simple"/></inline-formula> are defined as</p>
<p><xref ref-type="bibr" rid="pcbi.1000684-Teague1">[44]</xref><disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e079" xlink:type="simple"/><label>(5)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e080" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e081" xlink:type="simple"/></inline-formula> is even, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e082" xlink:type="simple"/></inline-formula>, and Zernike polynomials <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e083" xlink:type="simple"/></inline-formula> are a set of orthogonal functions. The background material on the Zernike polynomial is included in <xref ref-type="supplementary-material" rid="pcbi.1000684.s001">Text S1</xref>.</p>
</sec><sec id="s4c3">
<title>Clustering of phenotypic signatures</title>
<p>Clustering of phenotypic signatures contributes to the categorization of morphological features and to the subsequent correlation analysis of expression data. However, three issues need to be addressed: (i) colonies have heterogeneous morphologies for the same cell line; (ii) the number of colonies for each cell line is unequal, ranging from a dozen to several hundred independent samples; and (iii) there is no prior knowledge of the number of clusters. An important aspect of clustering has to do with validation, since some clustering methods (e.g., k-means) are sensitive to the initial conditions, and others simply quantize the space (e.g., hierarchical clustering) through an arbitrary threshold. A proven method is consensus clustering, which is widely used for class discovery and visualization of gene expression microarray data <xref ref-type="bibr" rid="pcbi.1000684-Monti2">[46]</xref>. This iterative method is based on resampling, and is designed to partition the observed gene expression profiles into a set of exhaustive and nonoverlapping clusters. In each iteration, clustering is performed on a random subset of the data, and the consensus across repeated runs is aggregated into a consensus matrix, which represents the probability that a pair of cell lines will be in the same cluster. Furthermore, visualization of the consensus matrix enables the qualitative evaluation of the clustering results (e.g., Are there crisp boundaries between clusters?). Our goal is to partition morphometric fingerprints of colonies associated with 24 cell lines into a set of exhaustive and nonverlapping clusters. We modified the consensus clustering method slightly:</p>
<list list-type="order"><list-item>
<p>Initialize the number of clusters to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e084" xlink:type="simple"/></inline-formula>.</p>
</list-item><list-item>
<p>Construct an equal number of samples, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e085" xlink:type="simple"/></inline-formula> (e.g., colony), from each of the 24 cell lines through random sampling.</p>
</list-item><list-item>
<p>Cluster <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e086" xlink:type="simple"/></inline-formula> randomly selected samples using the k-means method.</p>
</list-item><list-item>
<p>Construct a probability distribution function (PDF) for each cell line. This PDF indicates the assignment of samples to each cluster. In other words, each cell line will have its own unique PDF given the number of clusters.</p>
</list-item><list-item>
<p>Construct the similarity matrix whose elements correspond to the p-value computed through the Kolmogorov-Smirnov (KS), which compares pairwise similarities between two distributions.</p>
</list-item><list-item>
<p>Repeat steps 2 to 5 for a fixed number of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e087" xlink:type="simple"/></inline-formula> iterations, and compute the consensus matrix (e.g., average or median over all <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e088" xlink:type="simple"/></inline-formula> similarity matrices).</p>
</list-item><list-item>
<p>Increase <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e089" xlink:type="simple"/></inline-formula> and repeat steps 1 to 6 for each different <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e090" xlink:type="simple"/></inline-formula>.</p>
</list-item></list>
<p>The KS test is nonparametric, makes no assumption about the distribution of the data, and outputs a <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e091" xlink:type="simple"/></inline-formula> value between two distributions (e.g., <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e092" xlink:type="simple"/></inline-formula>). Each element of the similarity matrix <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e093" xlink:type="simple"/></inline-formula> is represented as <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e094" xlink:type="simple"/></inline-formula>, and the final consensus matrix is constructed by averaging all similarity matrices for all <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e095" xlink:type="simple"/></inline-formula> iterations. Subsequent visualization of the consensus matrix enables visual feedback for the performance of the clustering results. In our system, the number of iterations (e.g., <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e096" xlink:type="simple"/></inline-formula>) and samples (e.g., <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e097" xlink:type="simple"/></inline-formula>) are set at 100 and 6, respectively.</p>
</sec><sec id="s4c4">
<title>Identification of molecular predictors for morphological clusters</title>
<p>We have examined both linear and nonlinear methods for differential expression between different clusters. Additionally, the same biomarker has been identified through gene set enrichment analysis (GSEA) <xref ref-type="bibr" rid="pcbi.1000684-Subramanlan1">[47]</xref>. Results from GSEA and nonlinear analysis are shown in <xref ref-type="supplementary-material" rid="pcbi.1000684.s001">Text S1</xref>. Regardless of linear and nonlinear cases, the main challenge is the limited number of gene expression data. However, since the same biomarker has appeared in both cases, we are limiting our discussion to the linear method in the main body of text. In the nonlinear case, the cross-validation error of the SVM rule with Gaussian kernel is used for identifying differentially expressed genes <xref ref-type="bibr" rid="pcbi.1000684-Ambroise1">[48]</xref>. The details of the nonlinear method are summarized in <xref ref-type="supplementary-material" rid="pcbi.1000684.s001">Text S1</xref>.</p>
<p>In the linear case, gene selection is based on the moderated t-statistic <xref ref-type="bibr" rid="pcbi.1000684-Smyth1">[49]</xref>, which uses the empirical Bayes method for assessing differential gene expression. In the moderated t-statistic, ordinary standard deviations are replaced by posterior residual standard deviations, and the results are further moderated across genes through the empirical Bayes approach. The net result is an improved statistical stability given the limited number of samples. The p-value is computed for each gene based on the moderated t-statistic, and then adjusted for multiple hypothesis testing. The adjustment is based on Benjamini and Hochberg's method to estimate the false discovery rate (FDR) <xref ref-type="bibr" rid="pcbi.1000684-Benjamini1">[50]</xref>. FDR controls the expected proportion of falsely rejected null hypotheses in multiple hypothesis testing to correct for multiple comparisons. The method is implemented through the R <italic>limma</italic> package <xref ref-type="bibr" rid="pcbi.1000684-Smyth2">[51]</xref>.</p>
</sec></sec><sec id="s4d">
<title>Identification of molecular predictors for morphological features</title>
<p>Both linear and nonlinear prediction models are explored to identify molecular predictors. Each model produces a different view of the analysis for subsequent biological validation. In linear regression, the relationship between two variables (e.g., morphology index and gene expression) is given by<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e098" xlink:type="simple"/><label>(6)</label></disp-formula>where the coefficients <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e099" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e100" xlink:type="simple"/></inline-formula> are estimated by minimizing the <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e101" xlink:type="simple"/></inline-formula> norm (e.g., sum squared error): <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e102" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e103" xlink:type="simple"/></inline-formula> is known as the coefficient of determination in statistics and is the proportion of variability in a dataset that can be accounted for by the model. A general definition is given by the ratio of error in the fit (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e104" xlink:type="simple"/></inline-formula>) to sample variance (<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e105" xlink:type="simple"/></inline-formula>):<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e106" xlink:type="simple"/><label>(7)</label></disp-formula>where, as before, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e107" xlink:type="simple"/></inline-formula>. In linear regression, the square root of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e108" xlink:type="simple"/></inline-formula> equals the Pearson product-moment correlation coefficient:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e109" xlink:type="simple"/><label>(8)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e110" xlink:type="simple"/></inline-formula> is the sample mean and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e111" xlink:type="simple"/></inline-formula> is the sample standard deviation. Therefore, the Pearson product-moment correlation coefficient measures the quality of least squares fitting to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e112" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e113" xlink:type="simple"/></inline-formula> in Equation (6), i.e., the degree of linear relationship between two variables. A value of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e114" xlink:type="simple"/></inline-formula> indicates a perfect positive linear relationship, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e115" xlink:type="simple"/></inline-formula> means a perfect negative linear relationship.</p>
<p>In the nonlinear case, the relationship is modeled by a logistic function <xref ref-type="bibr" rid="pcbi.1000684-Carey1">[52]</xref>:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e116" xlink:type="simple"/><label>(9)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e117" xlink:type="simple"/></inline-formula> samples are normalized to reside between <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e118" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e119" xlink:type="simple"/></inline-formula>. Equation (9) can be rewritten as<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e120" xlink:type="simple"/><label>(10)</label></disp-formula>The Pearson product-moment correlation coefficient of the transformed variable <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e121" xlink:type="simple"/></inline-formula>measures the fitting quality of <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e122" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e123" xlink:type="simple"/></inline-formula> in Equation (10), as well as the quality of the logistic fitting to the original data <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e124" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e125" xlink:type="simple"/></inline-formula> in Equation (9).</p>
<p>In all cases, the p-value is computed through permutation. In each permutation step, a subset of the data is used to compute the corresponding Pearson product-moment correlation coefficients based on a higher-level taxonomy for genes being either positively or negatively correlated with morphogenesis. For each gene, from their respective taxonomy, a p-value is then computed by comparing its Pearson product-moment correlation coefficient <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e126" xlink:type="simple"/></inline-formula> with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e127" xlink:type="simple"/></inline-formula> values, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e128" xlink:type="simple"/></inline-formula>, from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e129" xlink:type="simple"/></inline-formula> permutated samples. For a gene with positive <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e130" xlink:type="simple"/></inline-formula> value, its p-value is:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e131" xlink:type="simple"/><label>(11)</label></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e132" xlink:type="simple"/></inline-formula> is <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e133" xlink:type="simple"/></inline-formula> if <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e134" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e135" xlink:type="simple"/></inline-formula> otherwise. For a gene with negative <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e136" xlink:type="simple"/></inline-formula> value, its p-value is:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e137" xlink:type="simple"/><label>(12)</label></disp-formula></p>
</sec><sec id="s4e">
<title>Validation</title>
<sec id="s4e1">
<title><italic>In vitro</italic> approach</title>
<p>In the first case, the triple-negative breast cancer cell line, MDA-MB-231, was assayed in 3D cell cultures maintained in H14 medium with <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e138" xlink:type="simple"/></inline-formula> fetal bovine serum. The 3D cultures were prepared in triplicate by seeding single cells on top of a thin layer of Matrigel (BD Biosciences; Franklin Lakes, NJ) at a density of 2,200 <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e139" xlink:type="simple"/></inline-formula> and overlaid by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e140" xlink:type="simple"/></inline-formula> final Matrigel diluted in a culture medium. GW9662 (Cayman Chemical; Ann Arbor, MI), a PPARG inhibitor, was dissolved in DMSO (Fisher Scientific; Hampton, NH) and added to the 3D cultures in the final concentration of 10 <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e141" xlink:type="simple"/></inline-formula>M at the time of seeding. The vehicle control was pure DMSO. The culture medium and the drug were changed every other day. Five images per well were collected after five full days in 3D culture on an Olympus IX 81 (Melville, NY) with 10× N.A. 0.25 Plan APO optics with a Cooke Sensicam QE air-cooled CCD camera, using IPLab 4.0.</p>
</sec><sec id="s4e2">
<title><italic>In vivo</italic> approach</title>
<p>The PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e142" xlink:type="simple"/></inline-formula> antibody, from the EnVision kit, was initially assayed at 1∶25, 1∶50, 1∶100, and 1∶200 dilution, with 1∶25 (1 <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e143" xlink:type="simple"/></inline-formula>L of antibody per 25 <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e144" xlink:type="simple"/></inline-formula>L of buffer) being selected as the optimal dilution. Detection was performed using the Envision System (DakoSytomation). Paraffin-embedded, triple-negative (from three different patients) and normal tissue sections were stained and scanned with an Aperio imaging system at 40×. Since these images have a very large format (e.g., approximately 50,000-by-50,000 pixels), they were randomly sampled for quantitative analysis. Each sampled sub-image is 1472-by-936 pixels, and the amount of nuclear-localized PPAR<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1000684.e145" xlink:type="simple"/></inline-formula> was quantified using a recently published method <xref ref-type="bibr" rid="pcbi.1000684-Chang1">[53]</xref>. All nuclear segmentations were manually corrected to exclude stromal cells based on their morphology.</p>
</sec></sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pcbi.1000684.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1000684.s001" xlink:type="simple"><label>Text S1</label><caption>
<p>This file contains supplementary materials. Section 1 shows how pure thresholding fails in delineating foreground and background. Section 2 provides a summary of Zernike polynomial for representing morphometric traits. Section 3 summarizes background on non-linear regression methods for identifying molecular targets. Section 4 provides comparative analysis with the Gene Set Enrichment Analysis (GSEA). Section 5 outlines the details of validation protocol that includes quantitative image analysis.</p>
<p>(0.78 MB PDF)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pcbi.1000684-Sharan1"><label>1</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Sharan</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Elkon</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Shamir</surname><given-names>R</given-names></name>
</person-group>             <year>2002</year>             <article-title>Clustering analysis and its applications to gene expression data.</article-title>             <source>Ernst Schering Res Found Workshop</source>             <volume>38</volume>             <fpage>83</fpage>             <lpage>108</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Hartigan1"><label>2</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hartigan</surname><given-names>J</given-names></name>
</person-group>             <year>1975</year>             <source>Clustering algorithms</source>             <publisher-name>Wiley</publisher-name>          </element-citation></ref>
<ref id="pcbi.1000684-Cheng1"><label>3</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Church</surname><given-names>G</given-names></name>
</person-group>             <year>2000</year>             <article-title>Biclustering of expression data.</article-title>             <source>Proc Int Conf Intell Syst Mol Biol</source>             <fpage>93</fpage>             <lpage>103</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Tanay1"><label>4</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Tanay</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Sharan</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Shamir</surname><given-names>R</given-names></name>
</person-group>             <year>2002</year>             <article-title>Discovering statistically significant biclusters in gene expression data.</article-title>             <source>Bioinformatics</source>             <volume>18</volume>             <fpage>136</fpage>             <lpage>144</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Yamanishi1"><label>5</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Yamanishi</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Vert</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Kanehisa</surname><given-names>M</given-names></name>
</person-group>             <year>2003</year>             <article-title>Extraction of correlated gene clusters from multiple genomic data by generalized kernel canonical correlation analysis.</article-title>             <source>Bioinformatics</source>             <volume>19</volume>             <fpage>323</fpage>             <lpage>330</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Yi1"><label>6</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Yi</surname><given-names>SG</given-names></name>
<name name-style="western"><surname>Park</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>
</person-group>             <year>2008</year>             <article-title>Response projected clustering for direct association with physiological and clinical response data.</article-title>             <source>BMC Bioinformatics</source>             <volume>9</volume>             <fpage>231</fpage>             <lpage>245</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-BarcellosHoff1"><label>7</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Barcellos-Hoff</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Aggeler</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ram</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Bissell</surname><given-names>M</given-names></name>
</person-group>             <year>1989</year>             <article-title>Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.</article-title>             <source>Development</source>             <volume>105</volume>             <fpage>223</fpage>             <lpage>235</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Gudjonsson1"><label>8</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gudjonsson</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Ronnov-Jessen</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Viladsen</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Rank</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Bissell</surname><given-names>M</given-names></name>
</person-group>             <year>2002</year>             <article-title>Normal and tumor derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.</article-title>             <source>J Cell Sci</source>             <volume>115</volume>             <fpage>39</fpage>             <lpage>50</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Emerman1"><label>9</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Emerman</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Pitelka</surname><given-names>D</given-names></name>
</person-group>             <year>1977</year>             <article-title>Maintenance and induction of morphological differentiation in dissociated mammary epithelium on floating collagen membranes.</article-title>             <source>In Vitro</source>             <volume>13</volume>             <fpage>316</fpage>             <lpage>28</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Petersen1"><label>10</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Petersen</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Ronnov-Jessen</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Howlett</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bissell</surname><given-names>M</given-names></name>
</person-group>             <year>1992</year>             <article-title>Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>89</volume>             <fpage>9064</fpage>             <lpage>8</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Monti1"><label>11</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Monti</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Tamayo</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Mesirov</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Golub</surname><given-names>T</given-names></name>
</person-group>             <year>2003</year>             <article-title>Consensus clustering: A resampling-based method for class discovery and visualization of gene expresssion microarray data.</article-title>             <source>Mach Learn</source>             <volume>52</volume>             <fpage>91</fpage>             <lpage>118</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Kenny1"><label>12</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kenny</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Myers</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Neve</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Semeiks</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression.</article-title>             <source>Mol Oncol</source>             <volume>1</volume>             <fpage>84</fpage>             <lpage>96</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Rakha1"><label>13</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Rakha</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Reis-Filho</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ellis</surname><given-names>I</given-names></name>
</person-group>             <year>2008</year>             <article-title>Basal-like breast cancer: a critical review.</article-title>             <source>J Clin Oncol</source>             <volume>26</volume>             <fpage>2568</fpage>             <lpage>81</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Chen1"><label>14</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chen</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Necela</surname><given-names>BM</given-names></name>
<name name-style="western"><surname>Su</surname><given-names>W</given-names></name>
<name name-style="western"><surname>Yanagisawa</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Anastasiadis</surname><given-names>PZ</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Peroxisome proliferator-activated receptor gamma promotes epithelial to mesenchymal transformation by rho gtpase-dependent activation of erk1/2.</article-title>             <source>J Biol Chem</source>             <volume>281</volume>             <fpage>24575</fpage>             <lpage>87</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Prunier1"><label>15</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Prunier</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Howe</surname><given-names>PH</given-names></name>
</person-group>             <year>2005</year>             <article-title>Disabled-2 (dab2) is required for transforming growth factor beta-induced epithelial to mesenchymal transition (emt).</article-title>             <source>J Biol Chem</source>             <volume>280</volume>             <fpage>17540</fpage>             <lpage>8</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Naik1"><label>16</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Naik</surname><given-names>MU</given-names></name>
<name name-style="western"><surname>Naik</surname><given-names>TU</given-names></name>
<name name-style="western"><surname>Suckow</surname><given-names>AT</given-names></name>
<name name-style="western"><surname>Duncan</surname><given-names>MK</given-names></name>
<name name-style="western"><surname>Naik</surname><given-names>UP</given-names></name>
</person-group>             <year>2008</year>             <article-title>Attenuation of junctional adhesion molecule-a is a contributing factor for breast cancer cell invasion.</article-title>             <source>Cancer Res</source>             <volume>68</volume>             <fpage>2194</fpage>             <lpage>203</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Nakamura1"><label>17</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Nakamura</surname><given-names>MT</given-names></name>
<name name-style="western"><surname>Nara</surname><given-names>TY</given-names></name>
</person-group>             <year>2002</year>             <article-title>Gene regulation of mammalian desaturases.</article-title>             <source>Biochem Soc Trans</source>             <volume>30</volume>             <fpage>1076</fpage>             <lpage>9</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Wang1"><label>18</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wang</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Xu</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Yu</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Yang</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Han</surname><given-names>ZC</given-names></name>
</person-group>             <year>2006</year>             <article-title>Peroxisome proliferator-activated receptor gamma in malignant diseases.</article-title>             <source>Crit Rev Oncol Hematol</source>             <volume>58</volume>             <fpage>1</fpage>             <lpage>14</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Timoshenko1"><label>19</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Timoshenko</surname><given-names>AV</given-names></name>
<name name-style="western"><surname>Xu</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Chakrabarti</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Lala</surname><given-names>PK</given-names></name>
<name name-style="western"><surname>Chakraborty</surname><given-names>C</given-names></name>
</person-group>             <year>2003</year>             <article-title>Role of prostaglandin e2 receptors in migration of murine and human breast cancer cells.</article-title>             <source>Exp Cell Res</source>             <volume>289</volume>             <fpage>265</fpage>             <lpage>74</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Ma1"><label>20</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ma</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Kundu</surname><given-names>N</given-names></name>
<name name-style="western"><surname>Rifat</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Walser</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Fulton</surname><given-names>AM</given-names></name>
</person-group>             <year>2006</year>             <article-title>Prostaglandin e receptor ep4 antagonism inhibits breast cancer metastasis.</article-title>             <source>Cancer Res</source>             <volume>66</volume>             <fpage>2923</fpage>             <lpage>7</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Miwa1"><label>21</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Miwa</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Masutani</surname><given-names>M</given-names></name>
</person-group>             <year>2007</year>             <article-title>Polyadp-ribosylation and cancer.</article-title>             <source>Cancer Sci</source>             <volume>98</volume>             <fpage>1528</fpage>             <lpage>35</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Cortes1"><label>22</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Cortes</surname><given-names>U</given-names></name>
<name name-style="western"><surname>Tong</surname><given-names>WM</given-names></name>
<name name-style="western"><surname>Coyle</surname><given-names>DL</given-names></name>
<name name-style="western"><surname>Meyer-Ficca</surname><given-names>ML</given-names></name>
<name name-style="western"><surname>Meyer</surname><given-names>RG</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Depletion of the 110-kilodalton isoform of poly(adp-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice.</article-title>             <source>Mol Cell Biol</source>             <volume>24</volume>             <fpage>7163</fpage>             <lpage>78</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Amirkhosravi1"><label>23</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Amirkhosravi</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Meyer</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Amaya</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Davila</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Mousa</surname><given-names>SA</given-names></name>
<etal/></person-group>             <year>2007</year>             <article-title>The role of tissue factor pathway inhibitor in tumor growth and metastasis.</article-title>             <source>Semin Thromb Hemost</source>             <volume>33</volume>             <fpage>643</fpage>             <lpage>52</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Hu1"><label>24</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hu</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Copeland</surname><given-names>NG</given-names></name>
<name name-style="western"><surname>Gilbert</surname><given-names>DJ</given-names></name>
<name name-style="western"><surname>Jenkins</surname><given-names>NA</given-names></name>
<name name-style="western"><surname>Kilimann</surname><given-names>MW</given-names></name>
</person-group>             <year>2001</year>             <article-title>The paralemmin protein family: identification of paralemmin-2, an isoform differentially spliced to akap2/akap-kl, and of palmdelphin, a more distant cytosolic relative.</article-title>             <source>Biochem Biophys Res Commun</source>             <volume>285</volume>             <fpage>1369</fpage>             <lpage>76</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Arstikaitis1"><label>25</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Arstikaitis</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Gauthier-Campbell</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Carolina Gutierrez Herrera</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Huang</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Levinson</surname><given-names>JN</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Paralemmin-1, a modulator of filopodia induction is required for spine maturation.</article-title>             <source>Mol Biol Cell</source>             <volume>19</volume>             <fpage>2026</fpage>             <lpage>38</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Koshikawa1"><label>26</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Koshikawa</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Osada</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Kozaki</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Konishi</surname><given-names>H</given-names></name>
<name name-style="western"><surname>Masuda</surname><given-names>A</given-names></name>
<etal/></person-group>             <year>2002</year>             <article-title>Significant up-regulation of a novel gene, clcp1, in a highly metastatic lung cancer subline as well as in lung cancers in vivo.</article-title>             <source>Oncogene</source>             <volume>21</volume>             <fpage>2822</fpage>             <lpage>8</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-KastWoelbern1"><label>27</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Kast-Woelbern</surname><given-names>HR</given-names></name>
<name name-style="western"><surname>Dana</surname><given-names>SL</given-names></name>
<name name-style="western"><surname>Cesario</surname><given-names>RM</given-names></name>
<name name-style="western"><surname>Sun</surname><given-names>L</given-names></name>
<name name-style="western"><surname>de Grandpre</surname><given-names>LY</given-names></name>
<etal/></person-group>             <year>2004</year>             <article-title>Rosiglitazone induction of insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis.</article-title>             <source>J Biol Chem</source>             <volume>279</volume>             <fpage>23908</fpage>             <lpage>15</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Li1"><label>28</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Li</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Ye</surname><given-names>X</given-names></name>
<name name-style="western"><surname>Tan</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Hongo</surname><given-names>JA</given-names></name>
<name name-style="western"><surname>Zha</surname><given-names>J</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Axl as a potential therapeutic target in cancer: role of axl in tumor growth, metastasis and angiogenesis.</article-title>             <source>Oncogene</source>          </element-citation></ref>
<ref id="pcbi.1000684-Dobashi1"><label>29</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Dobashi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Katagiri</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Hirota</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Ashida</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Daigo</surname><given-names>Y</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Involvement of tmem22 overexpression in the growth of renal cell carcinoma cells.</article-title>             <source>Oncol Rep</source>             <volume>21</volume>             <fpage>305</fpage>             <lpage>12</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Hoare1"><label>30</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Hoare</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Hoare</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Reinhard</surname><given-names>MK</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>YJ</given-names></name>
<name name-style="western"><surname>Oh</surname><given-names>SP</given-names></name>
<etal/></person-group>             <year>2008</year>             <article-title>Tnk1/kos1 knockout mice develop spontaneous tumors.</article-title>             <source>Cancer Res</source>             <volume>68</volume>             <fpage>8723</fpage>             <lpage>32</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Wells1"><label>31</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Wells</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Cai</surname><given-names>AQ</given-names></name>
<name name-style="western"><surname>Karapetyan</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>WJ</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Ovol2 suppresses cell cycling and terminal differentiation of keratinocytes by directly repressing c-myc and notch1.</article-title>             <source>J Biol Chem</source>          </element-citation></ref>
<ref id="pcbi.1000684-Chiu1"><label>32</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chiu</surname><given-names>ST</given-names></name>
<name name-style="western"><surname>Chang</surname><given-names>KJ</given-names></name>
<name name-style="western"><surname>Ting</surname><given-names>CH</given-names></name>
<name name-style="western"><surname>Shen</surname><given-names>HC</given-names></name>
<name name-style="western"><surname>Li</surname><given-names>H</given-names></name>
<etal/></person-group>             <year>2009</year>             <article-title>Over-expression of ephb3 enhances cell-cell contacts and suppresses tumor growth in ht-29 human colon cancer cells.</article-title>             <source>Carcinogenesis</source>             <volume>30</volume>             <fpage>1475</fpage>             <lpage>86</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Gill1"><label>33</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Gill</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Robert</surname><given-names>R</given-names></name>
</person-group>             <year>2003</year>             <article-title>PPARs and cancer.</article-title>             <comment>Protein-fatty acid interactions in the mammalian cell (editted), Sutta-Roy, A. and Spener, F. VCH-Wiley</comment>          </element-citation></ref>
<ref id="pcbi.1000684-Seargent1"><label>34</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Seargent</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Yates</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Gill</surname><given-names>J</given-names></name>
</person-group>             <year>2004</year>             <article-title>Gw9662, a potent antagonist of ppar<italic>γ</italic>, inhibits growth of breast tumour cells and promotes the anticancer effects of the ppar <italic>γ</italic> agonist rosiglitazone, independently of pparγ activation.</article-title>             <source>Br J Pharmacol</source>             <volume>143</volume>             <fpage>933</fpage>             <lpage>937</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Suzuki1"><label>35</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Suzuki</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Hayashi</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Miki</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Nakamura</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Moriya</surname><given-names>T</given-names></name>
<etal/></person-group>             <year>2006</year>             <article-title>Peroxisome proliferator-activated receptor γ in human breast carcinoma: a modulator of estrogenic actions.</article-title>             <source>Endocr Relat Cancer</source>             <volume>13</volume>             <fpage>233</fpage>             <lpage>250</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Briand1"><label>36</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Briand</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Petersen</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Van Deurs</surname><given-names>B</given-names></name>
</person-group>             <year>1987</year>             <article-title>A new diploid nontumorigenic human breast epithelial cell line isolated and propagated in chemically defined medium.</article-title>             <source>In Vitro Cell Dev Biol</source>             <volume>23</volume>             <fpage>181</fpage>             <lpage>188</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Briand2"><label>37</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Briand</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Nielsen</surname><given-names>K</given-names></name>
<name name-style="western"><surname>Madsen</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Petersen</surname><given-names>O</given-names></name>
</person-group>             <year>1996</year>             <article-title>Trisomy 7p and malignant transformation of human breast epithelial cells following epidermal growth factor withdrawal.</article-title>             <source>Cancer Res</source>             <volume>56</volume>             <fpage>2039</fpage>             <lpage>2044</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Petersen2"><label>38</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Petersen</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Ronnov-Jessen</surname><given-names>L</given-names></name>
<name name-style="western"><surname>Howlett</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Bissell</surname><given-names>M</given-names></name>
</person-group>             <year>1992</year>             <article-title>Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>89</volume>             <fpage>9064</fpage>             <lpage>9068</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Weaver1"><label>39</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Weaver</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Petersen</surname><given-names>O</given-names></name>
<name name-style="western"><surname>Wang</surname><given-names>F</given-names></name>
<name name-style="western"><surname>Larabell</surname><given-names>C</given-names></name>
<name name-style="western"><surname>Briand</surname><given-names>P</given-names></name>
<etal/></person-group>             <year>1997</year>             <article-title>Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies.</article-title>             <source>J Cell Biol</source>             <volume>137</volume>             <fpage>231</fpage>             <lpage>245</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Lee1"><label>40</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Lee</surname><given-names>G</given-names></name>
<name name-style="western"><surname>Kenny</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Lee</surname><given-names>E</given-names></name>
<name name-style="western"><surname>Bissell</surname><given-names>M</given-names></name>
</person-group>             <year>2007</year>             <article-title>3d culture models of normal and malignant breast epithelial cells.</article-title>             <source>Nat Methods</source>             <volume>4</volume>             <fpage>359</fpage>             <lpage>365</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Daugman1"><label>41</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Daugman</surname><given-names>J</given-names></name>
</person-group>             <year>1985</year>             <article-title>Uncertainty relation for resolution in space, spatial frequency, and orientation optimized by two-dimensional visual cortical filters.</article-title>             <source>J Opt Soc Am A</source>             <volume>2</volume>             <fpage>1160</fpage>             <lpage>9</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Han1"><label>42</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Han</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Ma</surname><given-names>KK</given-names></name>
</person-group>             <year>2007</year>             <article-title>Rotation-invariant and scale-invariant gabor features for texture image retrieval.</article-title>             <source>Image Vision Comput</source>             <volume>25</volume>             <fpage>1474</fpage>             <lpage>1481</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Manjunath1"><label>43</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Manjunath</surname><given-names>B</given-names></name>
<name name-style="western"><surname>Ma</surname><given-names>W</given-names></name>
</person-group>             <year>1996</year>             <article-title>Texture features for browsing and retrieval of image data.</article-title>             <source>IEEE T Pattern Anal</source>             <volume>18</volume>             <fpage>837</fpage>             <lpage>842</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Teague1"><label>44</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Teague</surname><given-names>M</given-names></name>
</person-group>             <year>1979</year>             <article-title>Image analysis via the general theory of moments.</article-title>             <source>J Opt Soc Amer</source>             <volume>70</volume>             <fpage>920</fpage>             <lpage>930</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Belkasim1"><label>45</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Belkasim</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Shridhar</surname><given-names>M</given-names></name>
<name name-style="western"><surname>Ahmadi</surname><given-names>M</given-names></name>
</person-group>             <year>1991</year>             <article-title>Pattern recognition with moment invariants: A comparative study and new results.</article-title>             <source>Pattern Recogn</source>             <volume>24</volume>             <fpage>1117</fpage>             <lpage>1138</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Monti2"><label>46</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Monti</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Tamayo</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Mesirov</surname><given-names>J</given-names></name>
<name name-style="western"><surname>Golub</surname><given-names>T</given-names></name>
</person-group>             <year>2003</year>             <article-title>Consensus clustering: A resampling-based method for class discovery and visualization of gene expression microarray data.</article-title>             <source>Mach Learn</source>             <volume>52</volume>             <fpage>91</fpage>             <lpage>118</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Subramanlan1"><label>47</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Subramanlan</surname><given-names>A</given-names></name>
<name name-style="western"><surname>Tamayo</surname><given-names>P</given-names></name>
<name name-style="western"><surname>Mootha</surname><given-names>V</given-names></name>
<name name-style="western"><surname>Mukherjee</surname><given-names>S</given-names></name>
<name name-style="western"><surname>Ebert</surname><given-names>B</given-names></name>
<etal/></person-group>             <year>2005</year>             <article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profile.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>102</volume>          </element-citation></ref>
<ref id="pcbi.1000684-Ambroise1"><label>48</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Ambroise</surname><given-names>C</given-names></name>
<name name-style="western"><surname>McLachlan</surname><given-names>G</given-names></name>
</person-group>             <year>2002</year>             <article-title>Selection bias in gene extraction on the basis of microarray gene-expression data.</article-title>             <source>Proc Natl Acad Sci USA</source>             <volume>99</volume>             <fpage>6562</fpage>             <lpage>6566</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Smyth1"><label>49</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Smyth</surname><given-names>GK</given-names></name>
</person-group>             <year>2004</year>             <article-title>Linear models and empirical bayes methods for assessing differential expression in microarray experiments.</article-title>             <source>Stat Appl GenetT Mo B</source>             <volume>3</volume>             <fpage>A3</fpage>          </element-citation></ref>
<ref id="pcbi.1000684-Benjamini1"><label>50</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Benjamini</surname><given-names>Y</given-names></name>
<name name-style="western"><surname>Hochberg</surname><given-names>Y</given-names></name>
</person-group>             <year>1995</year>             <article-title>Controlling the false discovery rate: a practical and powerful approach to multiple testing.</article-title>             <source>J Roy Stat Soc B</source>             <volume>57</volume>             <fpage>289</fpage>             <lpage>300</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Smyth2"><label>51</label><element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Smyth</surname><given-names>G</given-names></name>
</person-group>             <year>2005</year>             <article-title>Limma: linear models for microarray data.</article-title>             <fpage>397</fpage>             <lpage>420</lpage>             <comment>Bioinformatics and Computational Biology Solutions using R and Bioconductor (editted), R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber, Springer</comment>          </element-citation></ref>
<ref id="pcbi.1000684-Carey1"><label>52</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Carey</surname><given-names>M</given-names></name>
</person-group>             <year>1998</year>             <article-title>The enhanceosome and transcriptional synergy.</article-title>             <source>Cell</source>             <volume>92</volume>             <fpage>5</fpage>             <lpage>8</lpage>          </element-citation></ref>
<ref id="pcbi.1000684-Chang1"><label>53</label><element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author">
<name name-style="western"><surname>Chang</surname><given-names>H</given-names></name>
<name name-style="western"><surname>DeFilippis</surname><given-names>R</given-names></name>
<name name-style="western"><surname>Tlsty</surname><given-names>T</given-names></name>
<name name-style="western"><surname>Parvin</surname><given-names>B</given-names></name>
</person-group>             <year>2009</year>             <article-title>Graphical methods for quantifying macromolecules through bright field imaging.</article-title>             <source>Bioinformatics</source>             <volume>25</volume>             <fpage>1070</fpage>             <lpage>1075</lpage>          </element-citation></ref>
</ref-list>

</back>
</article>